Drvr.tiotr c~l ' l~~i t t i u t r Dcvc~lo/lt~ic,ti/ arid .-l~qrn,q. L'tii\8c,r\i/!. oi L'/n/r St,lrool c~/'.\t~~dit~itic~. .%I/ LuXc ('in.. 1 'rc~lr 8 4 / 3 2 ABSTRACT. In the human fetus, liver macrophages appear to be the primary source of erythropoietin (Epo). Epo production shifts from the liver to peritubular cells in the kidney sometime during the 3rd trimester. Some preterm infants experience a hyporegenerative anemia that appears to be caused by inadequate Epo production. Infants born prematurely may experience a prolonged hyporegenerative anemia. sometimes referred to as "the anemia of prematurity" (I). This normocytic, normochromic anemia often becomes apparent by the 3rd or 4th postnatal wk. Although some infants tolerate this condition without apparent difficulty. others demonstrate signs of anemia. such as an elevated heart rate. an increasing blood lactate concentration, and poor growth (2). The anemia of prematurity is characterized by inappropriately low serum concentrations of Epo (3), yet the underlying molecular mechanism responsible for the reduced Epo production remains undefined.
Infants born prematurely may experience a prolonged hyporegenerative anemia. sometimes referred to as "the anemia of prematurity" (I). This normocytic, normochromic anemia often becomes apparent by the 3rd or 4th postnatal wk. Although some infants tolerate this condition without apparent difficulty. others demonstrate signs of anemia. such as an elevated heart rate. an increasing blood lactate concentration, and poor growth (2) . The anemia of prematurity is characterized by inappropriately low serum concentrations of Epo (3), yet the underlying molecular mechanism responsible for the reduced Epo production remains undefined.
Zanjani el al. (4) showed the liver to be the primary source of Epo production in the fetus. They also determined that the anatomic site of Epo production shifts from the liver to the peritubular cells of the kidney sometime between the late 3rd trimester and the 1st mo of life. With immunoflorescent photomicroscopy, Gruber c. 1 al. (5) localized Epo production to macrophages within the fetal liver. It is unknown whether preterm infants rely on Epo produced by the liver, the kidney, or a combination of the two. The anemia of prematurity, therefore. might result from diminished production of Epo from liver macrophages or, alternatively, from a failure to initiate production of Epo in the kidney. As an initial model to evaluate macrophages from preterm infants. we devised studies to test whether circulating cord blood macrophages obtained from preterm infants could transcribe the Epo gene and assemble and export Epo protein as well as macrophages from term infants or from adults.
MATERIALS A N D M E T H O D S
Light-density mononuclear cells were isolated from the umbilical cord blood of five preterm (76 to 32 wk gestation) and five term (37 to 40 wk gestation) infants. and from the peripheral blood of five adults (6) . The cells were cultured in tu-minimum essential medium (Sigma Chemical Co., St. Louis. MO) with I "r nutridoma (Boehringer Mannheim. Indianapolis. IN), and incubated with plateau concentrations of recombinant macrophage colony stimulating factor (25 mg/L. R and D Systems. Minneapolis, MN), and recombinant granulocyte macrophage colony stimulating factor (2 mg/L. R and D Systems) to support the development of progenitor cells and monocytes into a macrophage phenotype. After 7 d of culture. the plates were washed of nonadherent cells. and new media. without additional growth factors. were added. The proportion of macrophages in the population was determined by tu-naphthyl-esterase staining (Sigma). The adherent macrophages were incubated for 14 h in either 1 % or 2 1 % oxygen environments. Oxygen determinations were made before and after incubation using a Hudson oxygen analyzer. Hep 3B cells (a human hepatoma cell line known to increase Epo production under hypoxic conditions) were used as a positive control (7) .
Media were collected after the 24-h incubation period and Epo protein concentration quantified by ELISA (R and D Systems). The cells were lysed with guanidinium thiocyanate, and total RNA was extracted using a rapid acid-phenol chloroform method (8) . The RNA was then reverse transcribed. and the resulting cDNA was amplified by polymerase chain reaction.
Primers for the Epo gene were chosen to span an intron. using a computerized primer selection program (DNA Stridor 1.0. Departement de Biologic. Cerex. France). Amplification of Epo cDNA would yield a 235-bp product. whereas amplification of contaminating genomic DNA (including the 133-bp intron) would yield a 368-bp product. The RNA samples were reverse transcribed with MMLV reverse transcriptase (Bethesda Research Laboratories. Gaithersburg, MD). and the DNA was amplified in a DNA thermal cycler for 30 cycles with Taq polymerase (Perkin-Elmer. Norwalk. CT). The polymerase chain reaction products were run on an ethidium bromide-stained agarose gel (FMC BioProducts. Rockland. ME) and photographed.
RESULTS
After 7 d of culture. macrophages accounted for more than 99% of the cells in the culture plates. Epo mRNA was detected in preterm. term. and adult macrophages (Fig. I) . No bands corresponding to contaminating genomic DNA were observed.
OHLS ET :1L
E r y t h r o p o~e t~n T r a n s c r~p t s appears to be stimulated by similar degrees of hypoxemia (9. 10): Accumulation of Epo by macrophages did not significantly increase under these conditions.
DISCUSSION
In the fetus, the liver macrophage appears to be the primary source of Epo production (4. 5. 9). At some point between the last trimester of gestation and the 1st postnatal mo of life. production of Epo shifts from the liver macrophage to peritubular cells in the kidney. The reason for this change in site of production is unknown.
Production of Epo by the fetal liver and postnatal kidney however a greater degree of hypoxemia is required for Epo production by adult liver macrophages. Both physiologic (hypoxia) and nonphysiologic (cobalt, nickel) stimuli appear to regulate production of Epo by increasing Epo gene expression ( 10. 1 1 ). Using an adult murine model. Rich ( 12) determined that bone marrow macrophages could produce Epo. The researcher also determined that macrophages were responsive to changes in oxygen tension and postulated that the macrophage could act as a regulator of erythropoiesis under steady state conditions. Infants born prematurely fail to increase Epo production significantly during anemia despite an apparent need for improved tissue oxygenation (1-3). It is unknown whether preterm infants rely on Epo production from liver macrophages. renal peritubular cells. or a combination of the two. The results of this study show that Epo mRNA and protein production appears to be intact in macrophages isolated from the cord blood of preterm infants. Although blood macrophages are easily accessible. they are an imperfect model for tissue macrophage function: whether these cells reflect the ability of liver macrophages to produce Epo in vivo remains to be determined. In addition, these macrophages did not respond to 1% oxygen to the same degree as murine macrophages isolated from bone marrow ( 12) . This finding may reflect a species difference or a cellular microenvironmental factor not present in vitro.
We speculate that because macrophages from preterm infants produce Epo to the same extent as term infants and adults do, it is doubtful that the anemia of prematurity is due to defective Epo production by macrophages. On this basis. we postulate that the defect involves a delay in shifting the anatomic site of Epo production from the liver to peritubular cells in the kidney. Studied aimed at determining the regulation of Epo gene expression in developing renal peritubular cells may help further clarify the molecular cause of the anemia of prematurity.
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